Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness

Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related death. Therapeutic options remain very limited and are based on classical chemotherapies. Energy metabolism reprogramming appears as an emerging hallmark of cancer and is considered a therapeutic target with conside...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncogene
Egile Nagusiak: Rademaker, Gilles, Hennequière, Vincent, Brohée, Laura, Nokin, Marie-Julie, Lovinfosse, Pierre, Durieux, Florence, Gofflot, Stéphanie, Bellier, Justine, Costanza, Brunella, Herfs, Michael, Peiffer, Raphael, Bettendorff, Lucien, Deroanne, Christophe, Thiry, Marc, Delvenne, Philippe, Hustinx, Roland, Bellahcène, Akeila, Castronovo, Vincent, Peulen, Olivier
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6085282/
https://ncbi.nlm.nih.gov/pubmed/29720728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0287-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak